The funding round was boosted by $30m after Reunion’s lead candidate RE104 hit efficacy goals in a Phase II trial.

Novo Nordisk announced that the European Medicines Agency (EMA) has approved an update to the label for Rybelsus (oral ...

Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.

Cadrenal Therapeutics has acquired eXIthera Pharmaceuticals' portfolio of Factor XIa inhibitors to expand its anticoagulation ...

The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

US-based Amneal Pharmaceuticals has secured approval from the FDA for its 500mg/mL sodium oxybate oral solution.

MSD has scrapped its UK expansion plans due to the government's lack of investment in the life sciences sector.

Zentiva, a Czech producer of generic medications, is poised for a change in ownership as Advent has agreed to sell the ...

A new report by trade body ABPI outlines an alarming drop in British life sciences investment as companies increasingly turn ...

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...